Pharmacological inactivation of the prion protein by targeting a folding intermediate
Open Access
- 12 January 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in Communications Biology
- Vol. 4 (1), 1-16
- https://doi.org/10.1038/s42003-020-01585-x
Abstract
Recent computational advancements in the simulation of biochemical processes allow investigating the mechanisms involved in protein regulation with realistic physics-based models, at an atomistic level of resolution. These techniques allowed us to design a drug discovery approach, named Pharmacological Protein Inactivation by Folding Intermediate Targeting (PPI-FIT), based on the rationale of negatively regulating protein levels by targeting folding intermediates. Here, PPI-FIT was tested for the first time on the cellular prion protein (PrP), a cell surface glycoprotein playing a key role in fatal and transmissible neurodegenerative pathologies known as prion diseases. We predicted the all-atom structure of an intermediate appearing along the folding pathway of PrP and identified four different small molecule ligands for this conformer, all capable of selectively lowering the load of the protein by promoting its degradation. Our data support the notion that the level of target proteins could be modulated by acting on their folding pathways, implying a previously unappreciated role for folding intermediates in the biological regulation of protein expression.Funding Information
- Fondazione Telethon (TCP14009)
This publication has 60 references indexed in Scilit:
- Energy landscape analysis of native folding of the prion protein yields the diffusion constant, transition path time, and ratesProceedings of the National Academy of Sciences of the United States of America, 2012
- DoGSiteScorer: a web server for automatic binding site prediction, analysis and druggability assessmentBioinformatics, 2012
- A Survey of Antiprion Compounds Reveals the Prevalence of Non-PrP Molecular TargetsJournal of Biological Chemistry, 2011
- Pharmacological chaperone for the structured domain of human prion proteinProceedings of the National Academy of Sciences of the United States of America, 2010
- Biological and Chemical Approaches to Diseases of Proteostasis DeficiencyAnnual Review of Biochemistry, 2009
- Cellular prion protein mediates impairment of synaptic plasticity by amyloid-β oligomersNature, 2009
- Single treatment with RNAi against prion protein rescues early neuronal dysfunction and prolongs survival in mice with prion diseaseProceedings of the National Academy of Sciences of the United States of America, 2008
- Thy-1, a versatile modulator of signaling affecting cellular adhesion, proliferation, survival, and cytokine/growth factor responsesBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2006
- Early Intermediate in Human Prion Protein Folding As Evidenced by Ultrarapid Mixing ExperimentsJournal of the American Chemical Society, 2006
- A Fast Flexible Docking Method using an Incremental Construction AlgorithmJournal of Molecular Biology, 1996